Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy

Autor: Zhenlong Shao, Hongbiao Huang, Jinchan He, Jinbao Liu, Daolin Tang, Xiaohong Xia, Yuan Liu, Chuyi Huang, Lili Jiang, Yuning Liao
Rok vydání: 2020
Předmět:
GRP78
Male
0301 basic medicine
Ubiquitin-Protein Ligases
Medicine (miscellaneous)
SIAH2
Protein degradation
Mice
03 medical and health sciences
Prostate cancer
Alkaloids
0302 clinical medicine
Cell Line
Tumor

Androgen Receptor Antagonists
medicine
Animals
Humans
Protein Isoforms
CRPC
Castration
Endoplasmic Reticulum Chaperone BiP
Pharmacology
Toxicology and Pharmaceutics (miscellaneous)

Heat-Shock Proteins
Mice
Inbred BALB C

biology
Chemistry
Cell growth
Ubiquitination
Nuclear Proteins
Rutaecarpine
Transfection
Cell cycle
medicine.disease
Antineoplastic Agents
Phytogenic

Xenograft Model Antitumor Assays
Ubiquitin ligase
rutaecarpine
Prostatic Neoplasms
Castration-Resistant

HEK293 Cells
030104 developmental biology
Receptors
Androgen

030220 oncology & carcinogenesis
Proteolysis
biology.protein
Cancer research
AR-V7
Research Paper
Zdroj: Theranostics
ISSN: 1838-7640
Popis: Rationale: Androgen receptor splice variant 7 (AR-V7) is a leading cause of the development of castration-resistant prostate cancer (CRPC). However, the regulation and function of AR-V7 at levels of post-translational modifications in prostate cancer therapy remain poorly understood. Here, we conducted a library screen of natural products to identify potential small molecules responsible for AR-V7 protein degradation in human prostate cancer cell lines. Methods: A natural product library was used to screen the inhibitor of AR-V7. Co-IP and biomass spectrum assays were used to identify the AR-V7-interacting proteins, whereas western blot, confocal microscopy, RNA interfering, and gene transfection were used to validate these interactions. Cell viability, EDU staining, and colony formation assays were employed to detect cell growth and proliferation. Flowcytometry assays were used to detect the distribution of cell cycle. Mouse xenograft models were used to study the anti-CRPC effects in vivo. Results: This screen identified rutaecarpine, one of the major components of the Chinese medicine Evodia rutaecarpa, as a novel chemical that selectively induces AR-V7 protein degradation via K48-linked ubiquitination. Mechanically, this effect relies on rutaecarpine inducing the formation of a GRP78-AR-V7 protein complex, which further recruits the E3 ligase SIAH2 to directly promote the ubiquitination of AR-V7. Consequently, the genetic and pharmacological activation of the GRP78-dependent AR-V7 protein degradation restores the sensitivity of castration-resistant prostate cancer to anti-androgen therapy in cell culture and animal models. Conclusions: These findings not only provide a new approach for overcoming castration-resistance in prostate cancer therapy, but also increase our understanding about the interplay between molecular chaperones and ubiquitin ligase in shaping protein stability.
Databáze: OpenAIRE